GOVXW

GeoVax Labs Warrants (GOVXW)

About GeoVax Labs Warrants (GOVXW)

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus, as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.

Details

Daily high
$0.14
Daily low
$0.13
Price at open
$0.15
52 Week High
$0.65
52 Week Low
$0.02
Market cap
--
Dividend yield
0.00%
Volume
4,713
Avg. volume
11,961
P/E ratio
--

GeoVax Labs Warrants News

Details

Daily high
$0.14
Daily low
$0.13
Price at open
$0.15
52 Week High
$0.65
52 Week Low
$0.02
Market cap
--
Dividend yield
0.00%
Volume
4,713
Avg. volume
11,961
P/E ratio
--